Findings

What do systematic reviews say?

50 questions · 53 findings · 3 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 16 · 30.2%GRADE not reported 6 · 11.3%Very low 8 · 15.1%Low 13 · 24.5%Moderate 8 · 15.1%High 2 · 3.8%

Intravenous magnesium sulphate vs placebo

Length of hospital stay · people with sickle cell disease

1 finding from 1 review

Magnesium for treating sickle cell disease 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 104 participants
Low

Intravenous magnesium sulphate vs placebo

Hypotension · people with sickle cell disease

Intravenous magnesium sulphate showed no clear difference in adverse effects: hypotension compared with placebo (low certainty).

1 finding from 1 review

Magnesium for treating sickle cell disease 2019 · Cochrane Headline outcomes only
RR 2.57 [0.5, 13.08]
2 studies · 306 participants
Low

Intravenous magnesium sulphate vs placebo

Adverse effects: warmth at infusion site · people with sickle cell disease

Intravenous magnesium sulphate may leads to higher adverse effects: warmth at infusion site compared with placebo (low certainty).

1 finding from 1 review

Magnesium for treating sickle cell disease 2019 · Cochrane Headline outcomes only
RR 13.26 [3.23, 54.4]
1 study · 202 participants
Low

Magnesium sulphate or magnesium sulphate + salbutamol vs salbutamol

Time to recovery · children from 1 month to 24 months old with acute bronchiolitis

The review found no eligible studies for this question.

1 finding from 1 review

Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Magnesium sulphate or magnesium sulphate + salbutamol vs salbutamol

All‐cause mortality · children from 1 month to 24 months old with acute bronchiolitis

1 finding from 1 review

Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
GRADE not reported

Magnesium sulphate or magnesium sulphate + salbutamol vs salbutamol

Adverse events · children from 1 month to 24 months old with acute bronchiolitis

1 finding from 1 review

Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
GRADE not reported

Magnesium sulphate or magnesium sulphate + salbutamol vs salbutamol

Length of hospital stay · children from 1 month to 24 months old with acute bronchiolitis

1 finding from 1 review

Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
GRADE not reported

Magnesium sulphate or magnesium sulphate + salbutamol vs salbutamol

Clinical severity score (CSS) (Wang score; range 0 to 12; higher = poorer outcome) measured at 0 to 24 hoursafter treatment · children from 1 month to 24 months old with acute bronchiolitis

The review found no eligible studies for this question.

1 finding from 1 review

Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Magnesium sulphate or magnesium sulphate + salbutamol vs salbutamol

Clinical severity score (CSS) (Wang score; range 0 to 12; higher = poorer outcome) measured 25 to 48 hoursafter treatment · children from 1 month to 24 months old with acute bronchiolitis

The review found no eligible studies for this question.

1 finding from 1 review

Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Magnesium sulphate or magnesium sulphate + salbutamol vs salbutamol

Hospital re‐admission within 30 days of discharge · children from 1 month to 24 months old with acute bronchiolitis

The review found no eligible studies for this question.

1 finding from 1 review

Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found